Skip to main content

SBI Q1 profit jumps 81% to Rs 4,189.34 crore

In June this year, SBI sold 2.1 percent equity stake in SBI Life Insurance Company via offer for sale route to comply with shareholding norms.


The country's biggest lender State Bank of India on July 31 reported a standalone profit of Rs 4,189.34 crore for the quarter ended June 2020, a growth of 81.2 percent over a year-ago period driven by stake sale in life insurance business, but the provisions and lower non-interest income limited growth.

Net interest income, the difference between interest earned and interest expended, increased 16.1 percent to Rs 26,641.56 crore in June quarter compared to Rs 22,938.8 crore in year-ago period.

Profit as well as NII both were ahead of a CNBC-TV18 poll estimates of Rs 3,222.2 crore and Rs 23,940.3 crore respectively.

In June this year, SBI sold 2.1 percent equity stake in SBI Life Insurance Company via offer for sale route to comply with shareholding norms and raised Rs 1,539.73 crore.

The provisions and contingencies at Rs 12,501.3 crore increased by 36.1 percent year-on-year including additional provision of Rs 1,836 crore on account of COVID-19 related accounts, adhoc provision of Rs 1,614 crore with respect to wage revision and Rs 5,230.4 crore towards fraud accounts. However, provisions on sequential basis fell 7.4 percent.

SBI said its provisions only for non-performing assets at Rs 9,420.46 crore declined sequentially (down 20.8 percent) as well as year-on-year (down 19.1 percent) for the quarter ended June 2020.

"The provision of Rs 3,008 crore is held by bank on COVID-19 related accounts as on June 2020," it added.

During June quarter, the bank has provided for entire balance amount of Rs 5,230.37 crore towards the above fraud accounts as against the quarterly requirement of Rs 1,743.46 crore.

Asset quality improved significantly in the quarter ended June 2020, with gross non-performing assets (NPA) as a percentage of gross advances falling 71 bps QoQ to 5.44 percent and net NPA declining 37 bps QoQ to 1.86 percent.

State Bank of India has reported a sharp decline in fresh slippages at Rs 3,637 crore in Q1FY21, compared to Rs 8,101 crore in Q4FY20.

The moratorium was at 9.5 percent of total loan book at the end of June quarter, against 23 percent in March quarter.

Out of 9.5 percent moratorium, SBI said 2 percent claimed by 'AA' and 'AAA' rated companies for preserving cash, while 4.2 percent has been claimed by retail and 3.3 percent claimed by private corporates.


Non-interest income fell 0.7 percent to Rs 7,957.48 crore during the quarter YoY, while pre-provision operating profit increased sharply by 24.7 percent to Rs 16,521.35 crore in Q1FY21 YoY.

The stock extended gains after earnings, trading 3.32 percent higher at Rs 192.75 on the BSE at the time of publishing this copy.

SBI share price fell 9 percent in June quarter and plunged 44 percent year-to-date amid fear of likely increase in asset quality concerns especially after the end of six-month moratorium on August 31.


Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...